Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

European Medicines Agency receives application for conditional marketing authorisation for Paxlovid

EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The applicant is Pfizer...

Nigeria is working to develop a COVID-19 vaccine, President Muhammadu Buhari said

Health experts say Nigeria needs to triple its vaccination drive from just over 100,000 doses a day to meet its target of inoculating more...

GMP-inspections of veterinary manufacturers in the second half of 2021

The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with the requirements of the Good Manufacturing Practice (GMP).

AstraZeneca and Neurimmune sign exclusive global collaboration to develop and commercialise NI006

Alexion, AstraZeneca’s Rare Disease group, has entered into an exclusive global collaboration and licence agreement with Neurimmune AG for NI006, an investigational human monoclonal...

The European Union shared 380 million doses COVID-19 vaccines with low and middle income countries in 2021

The European Union shared 380 million doses to low- and middle-income countries, mostly through COVAX, informed in the Statement by President von der Leyen...

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop mRNA-based Vaccine

Pfizer Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of...
spot_img

Expert Articles

spot_img